ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

DA-007

A development code.

Its studies are mostly in Alopecia, led by Applied Biology.

Furthest: phase 3, since Jan 1, 20251 company-led study, 1 open or runningNext primary completion: Mar 11, 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Applied Biology11 open or runningphase 3since Jan 1, 2025Jan 1, 2025Mar 11, 2028phase 3 · NCT06762548

Also a collaborator on its studies: Daniel Alain and Follea International.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 1, 2025First study: phase 3 study in Chemotherapy Induced AlopeciaFirst studyNCT06762548 · 140 planned · Italy
  2. Nov 2, 2026Primary completion moved from 2026-09-11 to 2028-03-11Date moved laterphase 3 · +18 months · NCT06762548

Ahead

  1. Mar 11, 2028Primary completion: phase 3 study in Chemotherapy Induced AlopeciaNCT06762548

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06762548Chemotherapy Induced Alopecia · Italy3Not yet recruitingMar 11, 2028140

How it is read

Names in the registry

  • “DA-007”, 1 entry

Codes read as this program: DA007.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.